Camilla Vittori

Camilla Vittori

PhD fellow

Member of:


    Publication year:
    All
    1 - 4 out of 4Page size: 10
    1. 2022
    2. Published

      Inhibition of oxidized nucleotide sanitation by TH1579 and conventional chemotherapy cooperatively enhance oxidative DNA-damage and survival in AML

      Centio, A., Estruch Alrich, Montserrat, Reckzeh, K., Sanjiv, K., Vittori, Camilla, Engelhard, Sophia Manon Charlotte, Warpman Berglund, U., Helleday, T. & Theilgaard-Mønch, Kim, 2022, In: Molecular Cancer Therapeutics. p. 703-714

      Research output: Contribution to journal › Journal article › Research › peer-review

    3. 2021
    4. Published

      Novel Combination Treatments for AML

      Estruch Alrich, Montserrat, Vittori, Camilla, Muñoz-Montesinos, T., Reckzeh, K. & Theilgaard-Mønch, Kim, 2021, In: Journal of Cellular Immunology. 3, 4, 6 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    5. Published

      Targeted inhibition of cooperative mutation- and therapy-induced AKT activation in AML effectively enhances response to chemotherapy

      Estruch Alrich, Montserrat, Reckzeh, K., Vittori, Camilla, Centio, A., Ali, M., Engelhard, Sophia Manon Charlotte, Zhao, L., Won, K. J., Liu, P., Porse, Bo Torben & Theilgaard-Mønch, Kim, 2021, In: Leukemia. 35, p. 2030-2042

      Research output: Contribution to journal › Journal article › Research › peer-review

    6. Published

      Targeting of PI3K/AKT signaling and DNA damage response in acute myeloid leukemia: a novel therapeutic strategy to boost chemotherapy response and overcome resistance

      Estruch Alrich, Montserrat, Vittori, Camilla, Montesinos, T. M., Reckzeh, K. & Theilgaard-Mønch, Kim, 2021, In: Cancer Drug Resistance. 4, p. 984-995

      Research output: Contribution to journal › Journal article › Research › peer-review

    ID: 195574652